Hseli, Jakob Schattenfroh, Tom Meyer, Paul Spiesecke, Tobias Puengel, Florian Roner, Bernhard Gebauer, Raphael Mohr, Mnevver Demir, Frank Tacke, Ingolf Sack, Rolf Reiter Journal of the Mechanical Behavior of Biomedical Materials .2026
Wilson, A
Research indicates that the activation of GLP-1R can alter the polarization of microglia, shifting them from a proinflammatory (M1) phenotype to an anti-inflammatory (M2) phenotype ( 3 GLP-1R as a link between DM and AD Our previous chapter discussed the role of GLP-1R in AD
However, the FDA There is an intense race among pharmaceutical companies to enter the GLP-1 medication market, especially in countries outside the United States, where patents are expiring
North America led the market in 2024 with over 50.14% share, generating around USD 5.4 Billion in revenue
A.SierraJ